X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

AI Assesses The Enzyme Functions Finer Than Leading Tools

Content Team by Content Team
4th April 2023
in IPR Data Management, News
AI Assesses The Enzyme Functions Finer Than Leading Tools

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

A novel artificial intelligence tool can help predict the functions of enzymes on the basis of their amino acid sequences, even when the enzymes are unstudied or not clearly understood.

As per the researchers, the AI tool called CLEAN outshines the leading top-notch tools in accuracy, dependency, and sensitivity. Apparently, a clearer understanding of enzymes as well as their functions will prove to be a big push for research as far as chemistry, genomics, medicine, pharma, industrial materials, etc. are concerned.

The study leader, Huimin Zhao, from the University of Illinois, states that just as the ChatGPT makes use of the data from written languages to create predictive text, they happen to be leveraging the protein language so as to predict their activity. He adds that almost all the researchers, when working on a novel protein sequence, intend to know without delay what the protein is up to. Besides, when it comes to making any applications, be it in medicine, biology, or industry, this tool will aid researchers in rapidly identifying the appropriate enzymes that are required for the synthesis of materials and chemicals.

The researchers are on the verge of publishing their assessment and, thereby, making CLEAN accessible online from March 31.

Due to the advances made in genomics, numerous enzymes have been pinpointed as well as sequenced, but the researchers have little or no data on what the enzymes are up to, commented Zhao, one of the members of the Carl R. Woese Institute at Illinois.

Apart from this, other computational tools intend to predict the enzyme functions. They look to assign an enzyme commission number, which happens to be an ID code that puts into focus what kind of reaction an enzyme can catalyse by way of comparing queried sequences to that of the enzyme catalogue as well as findings that are of similar sequences. That said, these tools do not work as well as they should with the less studied enzymes or even with enzymes that are known to perform multiple tasks.

Zhao adds that they aren’t the first when it comes to using the AI tools to forecast the enzyme commission numbers, but they are indeed the first to use the novel deep learning algorithm that happens to be working much better as compared to the AI tools used by others.

There is no guarantee that everybody’s product will be accurately predicted, but having said that, there is always the possibility of getting more accuracy compared to the other couple of methods.

The researchers have already verified the tool by way of an experiment using both in vitro and computational experiments. The inference was that not only was the tool able to predict the operations of the previously uncharacterized enzymes, but the correction of mislabelled enzymes by a leading software was done with either two or more functions.

Apparently, Zhao’s group is planning to make CLEAN accessible online so that other researchers who are looking to characterise an enzyme or gauge whether it could catalyse a desired location can do so. They hope that this tool is going to be helpful and used widely by the broad research community. The researchers just have to enter the sequence in a search box by way of a web interface and get the results.

As per Zhao, the group is planning to broaden the AI behind CLEAN so as to characterise certain other proteins as well, like the binding ones. The team is hopeful about further developing the machine learning algorithms so that the users search for a desired location and the AI pinpoints the proper enzyme for the job.

He further opines that there are many uncharacterized binding proteins, like the receptors, as well as transcription factors. They are looking to predict the functions of each and every protein so they are able to gauge all the proteins a cell has and thereby better study the entire cell for applications related to biomedical or biotech.

Previous Post

Regulatory Actions Needed For Gaps In Cancer Drug Info

Next Post

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
FDA Grants Fast Track Designation to CERC-002 for Treatment of Hospitalized Patients with COVID-19

COVID-19 Hospitalisation Dips Using Monoclonal Antibodies

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In